🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 661.43 -1.4% NASDAQ 100: 594.90 -1.4% Dow Jones: 463.00 -1.7%

Steven Cohen’s IRMD Holdings & Trades

First Buy
Q4 2015
Duration Held
6 Quarters
Largest Add
Q3 2025
+11,210 Shares
Current Position
10,982 Shares
$1.07 M Value

Steven Cohen's IRMD Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 10,982 shares of IRADIMED CORPORATION (IRMD) worth $1.07 M, representing 0.00% of the portfolio. First purchased in 2015-Q4, this short-term holding has been held for 6 quarters.

Based on 13F filings, Steven Cohen has maintained this position in IRMD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 11,210 shares. Largest reduction occurred in Q3 2023, reducing 502 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's IRADIMED CORPORATION (IRMD) Holding Value Over Time

Track share changes against reported price movement

Quarterly IRADIMED CORPORATION (IRMD) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -228 Reduce 2.03% 10,982 $97.28
Q3 2025 +11,210 New Buy 11,210 $71.16
Q3 2023 -502 Sold Out 0 $0.00
Q2 2023 +502 New Buy 502 $47.71
Q1 2016 -100 Sold Out 0 $0.00
Q4 2015 +100 New Buy 100 $30.00

Steven Cohen's IRADIMED CORPORATION Investment FAQs

Steven Cohen first purchased IRADIMED CORPORATION (IRMD) in Q4 2015, acquiring 100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held IRADIMED CORPORATION (IRMD) for 6 quarters since Q4 2015.

Steven Cohen's largest addition to IRADIMED CORPORATION (IRMD) was in Q3 2025, adding 11,210 shares worth $797,709.

According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 10,982 shares of IRADIMED CORPORATION (IRMD), valued at approximately $1.07 M.

As of the Q4 2025 filing, IRADIMED CORPORATION (IRMD) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in IRADIMED CORPORATION (IRMD) was 11,210 shares, as reported at the end of Q3 2025.